3D BioFibR presents two CollaFibR Tissue Engineering Products

3DBioFibR, a leader in tissue engineering, announced the launch of two new collagen fiber products: μCollaFibR (pronounced micro-CollaFibR) and CollaFibR 3D Scaffold.

Both collagen fiber products, manufactured using 3DBioFibR’s new proprietary dry spinning process, offer significant advantages for tissue engineering and tissue culture applications.

μCollaFibR is a bioink additive for 3D bioprinting of tissue and organ models. As an additive to bioinks, it improves the mechanical resistance of printed tissue, enabling layer-by-layer bonding of different cell types.

“3D bioprinting is the future of regenerative medicine and it’s exciting to offer μCollaFibR to enhance the capabilities in 3D bioprinting,” said Kevin Sullivan, CEO of 3D BioFibR. “We all want to imagine a future where doctors could just print a kidney, using cells from the patient, instead of having to find a donor match. Our collagen fibers represent a significant improvement over existing scaffolds used in 3D bioprinting, moving the field closer to this reality.”

The CollaFibR scaffold enables researchers* to study cellular responses in a more physiologically relevant 3D environment than in conventional 2D cultures. It uses GMP type 1 collagen and forms a consistent collagen fiber matrix that resembles the natural cellular environment.

Sullivan added, “Our CollaFibR scaffold allows cells to grow and interact with the surrounding cellular scaffold in 3D, making it ideal for creating realistic tissue constructs for laboratory testing of new drugs and tissue models. Plus, our standard well plate dimensions are compatible with automated equipment for high throughput compound screening and advanced microscopy.”